Marion Subklewe

LMU University Hospital

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (10)

Klaus Metzeler

Professor of Translational Hematology

Leipzig University

GERMANY

View details

Christian Chabannon

Professor in Cell Biology

Aix-Marseille Université Faculté de Medecine

FRANCE

View details

Wolfgang G. Kunz

University Hospital

GERMANY

View details

Michael Menden

University of Melbourne

AUSTRALIA

View details

Philipp Karschnia

LMU University Hospital

GERMANY

View details

Eva Hoster

University Hospital, LMU Munich

GERMANY

View details

Reuben Benjamin

Consultant Haematologist and Clinical Senior Lecturer

King's College Hospital

UNITED KINGDOM

View details

Konstantin Hellwig

University of Erlangen-Nuremberg

GERMANY

View details

Sebastian Theurich

Oberarzt, Hämatologie und Onkologie, W2 Professor für Krebs- und Immunmetabolismus

Klinikum der Universität München

GERMANY

View details

Viktoria Blumenberg

Klinikum der Universität München

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marion Subklewe

Research Interests

Explore related searches

Contact this professor

Articles (11)

WT1 and DNMT3A play essential roles in the growth of certain patient AML cells in mice

Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy

Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably to DLBCL: a GLA/DRST registry study

The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma

Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy

The race is on: bispecifics vs CAR T-cells in B-cell lymphoma

Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

Collaborators (10)

Klaus Metzeler

Christian Chabannon

Wolfgang G. Kunz

Michael Menden

Philipp Karschnia

Eva Hoster

Reuben Benjamin

Konstantin Hellwig

Sebastian Theurich

Viktoria Blumenberg

Make your next move.